Company: MYGN
Filing Date: 2025-05-06
Form Type: 8-K
Source: 0000899923-25-000045
Chunk: 1

Company: MYRIAD GENETICS INC
Filing Date: 2025-05-06
Form: 8-K
Item: Item 9.01
Chunk 1
---
ITEM 9.01 Financial Statements and Exhibits.

  Exhibit      Description                                                                       
   Number                                                                                        
     99.1      Earnings release dated May 6, 20 2 5 for the three months ended March 31, 20 25.  
 ─────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document).      

The exhibit(s) may contain hypertext links to information on our website or other parties’ websites. The information on our website and other parties’ websites is not incorporated by reference into this Current Report on Form 8-K and does not constitute a part of this Current Report on Form 8-K.

Limitation on Incorporation by Reference. In accordance with General Instruction B-2 of Form 8-K, the information set forth in Item 2.02 and in Exhibit 99.1 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  MYRIAD GENETICS, INC.                               
  By:                        /s/ Scott J. Leffler     
                             Scott J. Leffler         
                             Chief Financial Officer